Senior Scientist, Consultant

Ms. Schechtman is the former head of laboratory activities at Neurogenic and was one of the inventors of the schizophrenia immunoassay, along with Dr. Michael Deckmann, in the group of Prof. Meir Shinitzky. An organic chemist by training, Ms. Schechtman successfully completed the technology transfer process from the previous Neurogenic lab in the Weizmann Institute to the company's new facility in Weizmann Science Park, Ness Tziona, the cradle of Israeli biotech. After her recent retirement from the Weizmann Institute, she continues to be actively involved in the development of the assay in an advisory capacity.